Roger Song
Stock Analyst at Jefferies
(3.15)
# 2,613
Out of 4,630 analysts
258
Total ratings
41.4%
Success rate
2.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIOA BioAge Labs | Maintained: Buy | $62 → $21 | $11.72 | +79.18% | 7 | Jul 31, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $101 | $34.26 | +194.80% | 12 | Jul 30, 2026 | |
| MANE Veradermics | Maintained: Buy | $182 | $114.39 | +59.10% | 5 | Jul 16, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $83 | $49.76 | +66.80% | 6 | Jul 14, 2026 | |
| KRYS Krystal Biotech | Rated: Buy | $371 → $474 | $326.45 | +45.20% | 3 | Jul 13, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $733 → $714 | $538.84 | +32.51% | 16 | Jul 10, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $45 | $25.53 | +76.26% | 6 | Jul 8, 2026 | |
| KLRA Kailera Therapeutics | Maintained: Buy | $48 | $18.66 | +157.23% | 3 | Jul 8, 2026 | |
| AVLN Avalyn Pharma | Initiated Coverage: Buy | $52 | $33.92 | +53.30% | 1 | May 26, 2026 | |
| SABS SAB Biotherapeutics | Initiated Coverage: Buy | $11 | $3.90 | +182.05% | 1 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $2.80 | +42.86% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $71 | $76.06 | -6.65% | 6 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.01 | +397.51% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 → $2 | $12.06 | -83.42% | 15 | Apr 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $18 | $6.10 | +195.08% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.79 | +401.79% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $16 | $3.46 | +362.43% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $98.82 | -54.46% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $53.14 | +135.23% | 17 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $42 | $13.92 | +201.72% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $154 | $77.33 | +99.15% | 6 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 | $76.48 | +58.21% | 11 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $9.57 | +192.58% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $6.67 | +139.88% | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $40 | $25.38 | +57.60% | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.26 | +296.83% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $17 | $0.5114 | +3,224.21% | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $4 | $2.11 | +89.57% | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $67.82 | -46.92% | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.8 → $1.8 | $0.668 | +169.46% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $3.08 | n/a | 16 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $0.5505 | n/a | 4 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $5.91 | n/a | 13 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 | $145.87 | n/a | 6 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.9099 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $146 | $58.07 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $18 | $1.73 | n/a | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $3.52 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0001 | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $32.43 | n/a | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $25 | $7.95 | n/a | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $1.5 | $4.76 | n/a | 6 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $3 | $16.84 | n/a | 5 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $68 | $41.75 | n/a | 2 | Nov 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $4.90 | n/a | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $157.77 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $1.87 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $10.15 | n/a | 1 | Apr 13, 2021 |
BioAge Labs
Jul 31, 2026
Maintained: Buy
Price Target: $62 → $21
Current: $11.72
Upside: +79.18%
Viking Therapeutics
Jul 30, 2026
Maintained: Buy
Price Target: $101
Current: $34.26
Upside: +194.80%
Veradermics
Jul 16, 2026
Maintained: Buy
Price Target: $182
Current: $114.39
Upside: +59.10%
TG Therapeutics
Jul 14, 2026
Maintained: Buy
Price Target: $83
Current: $49.76
Upside: +66.80%
Krystal Biotech
Jul 13, 2026
Rated: Buy
Price Target: $371 → $474
Current: $326.45
Upside: +45.20%
United Therapeutics
Jul 10, 2026
Maintained: Buy
Price Target: $733 → $714
Current: $538.84
Upside: +32.51%
Nurix Therapeutics
Jul 8, 2026
Maintained: Buy
Price Target: $45
Current: $25.53
Upside: +76.26%
Kailera Therapeutics
Jul 8, 2026
Maintained: Buy
Price Target: $48
Current: $18.66
Upside: +157.23%
Avalyn Pharma
May 26, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $33.92
Upside: +53.30%
SAB Biotherapeutics
May 20, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.90
Upside: +182.05%
May 19, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $2.80
Upside: +42.86%
Apr 28, 2026
Maintained: Buy
Price Target: $58 → $71
Current: $76.06
Upside: -6.65%
Apr 15, 2026
Maintained: Buy
Price Target: $10
Current: $2.01
Upside: +397.51%
Apr 12, 2026
Downgraded: Hold
Price Target: $8 → $2
Current: $12.06
Upside: -83.42%
Mar 26, 2026
Rated: Buy
Price Target: $26 → $18
Current: $6.10
Upside: +195.08%
Mar 23, 2026
Maintained: Buy
Price Target: $14
Current: $2.79
Upside: +401.79%
Mar 18, 2026
Reiterated: Buy
Price Target: $8 → $16
Current: $3.46
Upside: +362.43%
Mar 11, 2026
Maintained: Buy
Price Target: $45
Current: $98.82
Upside: -54.46%
Feb 27, 2026
Maintained: Buy
Price Target: $125
Current: $53.14
Upside: +135.23%
Jan 22, 2026
Maintained: Buy
Price Target: $13 → $42
Current: $13.92
Upside: +201.72%
Dec 19, 2025
Maintained: Buy
Price Target: $154
Current: $77.33
Upside: +99.15%
Dec 17, 2025
Maintained: Buy
Price Target: $121
Current: $76.48
Upside: +58.21%
Dec 10, 2025
Maintained: Buy
Price Target: $28
Current: $9.57
Upside: +192.58%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $6.67
Upside: +139.88%
Sep 9, 2025
Maintained: Buy
Price Target: $80 → $40
Current: $25.38
Upside: +57.60%
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.26
Upside: +296.83%
Aug 22, 2025
Maintained: Buy
Price Target: $9 → $17
Current: $0.5114
Upside: +3,224.21%
Aug 20, 2025
Maintained: Buy
Price Target: $12 → $4
Current: $2.11
Upside: +89.57%
Aug 15, 2025
Initiated Coverage: Buy
Price Target: $36
Current: $67.82
Upside: -46.92%
Aug 13, 2025
Maintained: Buy
Price Target: $4.8 → $1.8
Current: $0.668
Upside: +169.46%
Jun 26, 2025
Maintained: Buy
Price Target: $28
Current: $3.08
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $10 → $8
Current: $0.5505
Upside: n/a
Apr 24, 2025
Maintained: Buy
Price Target: $7
Current: $5.91
Upside: n/a
Apr 10, 2025
Maintained: Buy
Price Target: $68
Current: $145.87
Upside: n/a
Apr 1, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $0.9099
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $146
Current: $58.07
Upside: n/a
Mar 26, 2025
Rated: Buy
Price Target: $12 → $18
Current: $1.73
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: $7
Current: $3.52
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $8
Current: $0.0001
Upside: n/a
Jan 10, 2025
Rated: Buy
Price Target: $35
Current: $32.43
Upside: n/a
Oct 16, 2024
Maintained: Buy
Price Target: $31 → $25
Current: $7.95
Upside: n/a
Aug 21, 2024
Downgraded: Hold
Price Target: $14 → $1.5
Current: $4.76
Upside: n/a
Mar 27, 2024
Maintained: Buy
Price Target: $5 → $3
Current: $16.84
Upside: n/a
Nov 5, 2023
Rated: Buy
Price Target: $68
Current: $41.75
Upside: n/a
Jul 29, 2022
Initiated Coverage: Buy
Price Target: $9
Current: $4.90
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $6
Current: $157.77
Upside: n/a
Apr 29, 2021
Maintained: Buy
Price Target: $23
Current: $1.87
Upside: n/a
Apr 13, 2021
Initiated Coverage: Buy
Price Target: $29
Current: $10.15
Upside: n/a